RELIEF: Randomized Episodic Versus Long-Term Suppression Experience With Famciclovir

NCT00219310 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Recurrent Genital Herpes (RGH)

Interventions

DRUG: Famciclovir

Sponsor

Novartis